The Latest Breaking News from ANTX

RA Capital-Backed AN2 Therapeutics Hits NASDAQ, With IPO Price At $15

AN2 Therapeutics Inc (NASDAQ:ANTX) will be offering 4.6 million shares at $15 a share in its initial public offering, under the ticker 'ANTX,' raising $69 million.  The Company announced IPO plans earlier this month.  The price point came in at the middle of AN2's expected range after setting terms of $14 to $16…

Benzinga · Mar 25, 2022

Preview: An2 Therapeutics, Inc Set To IPO Tomorrow

AN2 Therapeutics, Inc (NASDAQ:ANTX) IPO will take place March, 25 on the NASDAQ exchange under the ticker ANTX. The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on September 21, 2022.

Benzinga · Mar 24, 2022

Lung-Disease Focused AN2 Therapeutics Files Plans For NASDAQ Debut

AN2 Therapeutics Inc filed plans on Friday to go public in an initial public offering in which it reportedly hopes to raise about $75 million. AN2 plans to list on the Nasdaq with the symbol of ANTX. The Menlo Park-based biotech is developing a therapy for non-tuberculous mycobacterial (NTM) lung disease, which…

Benzinga · Mar 7, 2022